0001179110-12-004229.txt : 20120305
0001179110-12-004229.hdr.sgml : 20120305
20120305161239
ACCESSION NUMBER: 0001179110-12-004229
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120301
FILED AS OF DATE: 20120305
DATE AS OF CHANGE: 20120305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP
CENTRAL INDEX KEY: 0001157601
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
BUSINESS ADDRESS:
STREET 1: 45 HARTWELL AVE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 781-274-8200
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Koya Keizo
CENTRAL INDEX KEY: 0001325718
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33277
FILM NUMBER: 12666844
MAIL ADDRESS:
STREET 1: C/O SYNTA PHARMACEUTICALS CORP.
STREET 2: 45 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
edgar.xml
FORM 4 -
X0304
4
2012-03-01
0
0001157601
SYNTA PHARMACEUTICALS CORP
SNTA
0001325718
Koya Keizo
C/O SYNTA PHARMACEUTICALS CORP.
45 HARTWELL AVENUE
LEXINGTON
MA
02421
0
1
0
0
Sr. VP, Drug Development
Common Stock
2012-03-01
4
S
0
6844
4.703
D
12999
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2011, and were made in part to fund certain out-of-pocket tax withholding liabilities associated with the vesting of restricted stock granted on March 1, 2011.
The shares were sold in multiple transactions at prices ranging from $4.63 to $4.83 per share. The price reported above is the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the staff of the SEC, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Ann Margaret Eames, Attorney-in-Fact
2012-03-05